Doctor profile · Federal record
Dr. KENNETH ABBOTT, M.D.
Hematology & Oncology Physician (CMS: MEDICAL ONCOLOGY) · PRINCE FREDERICK, MD
- NPI 1306976949
- Accepts Medicare
- MIPS 91.4 / 100 · 2023
- 41 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
110 HOSPITAL RD STE 105
PRINCE FREDERICK, MD 206784043
(410) 414-9116
fax (410) 414-9118
Credentials & registration
- NPI registered
- March 2007 — 19 yrs on file
- Profile last updated
- January 16, 2024
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Maryland #D56024
- Medicaid
- MD #483400300
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1306976949. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
65,378
Distinct HCPCS
10
Medicare allowed
$477,753
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 42,000 | 39 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 10,300 | 13 | $3 | |
J0897 |
Injection, denosumab, 1 mg | 5,880 | 30 | $23 | |
J1756 |
Injection, iron sucrose, 1 mg | 4,800 | 13 | $0 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 538 | 88 | $184 | |
J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 492 | 12 | $96 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 421 | 205 | $92 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 186 | 103 | $128 | |
96372 |
Injection of drug or substance under skin or into muscle | 141 | 61 | $15 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 88 | 28 | $136 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 2,842. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$63
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $48.39 | |
| Alexion Pharmaceuticals, Inc. | 1 | $15.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
310
Patients
48
Total drug cost
$1,225,030
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 61 | 17 | $1,757 |
| Ondansetron Hcl | Generic | 27 | 18 | $526 |
| Prochlorperazine Maleate | Generic | 27 | 13 | $561 |
| Revlimid (Lenalidomide) | Brand | 23 | 0 | $440,946 |
| Hydroxyurea | Generic | 20 | 0 | $607 |
| Deferasirox | Generic | 19 | 0 | $62,631 |
| Oxycodone Hcl | Generic | 19 | 0 | $666 |
| Warfarin Sodium | Generic | 19 | 0 | $174 |
| Bicalutamide | Generic | 16 | 0 | $524 |
| Tasigna (Nilotinib Hcl) | Brand | 15 | 0 | $298,427 |